Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine: pharmacologic and therapeutic aspects.

M Velasco1, A Luchsinger

  • 1Clinical Pharmacology Unit, José M. Vargas Medical School, Universidad Central de Venezuela, Caracas, Venezuela.

American Journal of Therapeutics
|March 31, 1999
PubMed
Summary

Dopamine agonists and antagonists impact cardiovascular, hormonal, and nervous systems by targeting dopamine receptors. These compounds are vital for treating conditions like Parkinson's disease, hyperprolactinemia, and psychosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the relative prompt production rate of <i>χ</i><sub>c2</sub> and <i>χ</i><sub>c1</sub> in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Jet and underlying event properties as a function of charged-particle multiplicity in proton-proton collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Measurement of the sum of WW and WZ production with W+dijet events in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Search for displaced supersymmetry in events with an electron and a muon with large impact parameters.

Physical review letters·2015
Same author

Study of vector boson scattering and search for new physics in events with two same-sign leptons and two jets.

Physical review letters·2015
Same author

Measurement of prompt ψ(2S) to J/ψ yield ratios in Pb-Pb and p-p collisions at sqrt[sNN]=2.76  TeV.

Physical review letters·2015

Area of Science:

  • Neuropharmacology
  • Endocrinology
  • Cardiovascular Physiology

Background:

  • Dopamine, a crucial biogenic amine, is synthesized in various nervous system areas, including the hypothalamus.
  • Dopamine and its agonists modulate cardiovascular, renal, hormonal, and central nervous system functions via adrenergic and dopaminergic receptors.

Purpose of the Study:

  • To review the roles of dopamine receptor agonists and antagonists.
  • To highlight their therapeutic applications in diverse medical conditions.

Main Methods:

  • Review of existing literature on dopamine receptor pharmacology.
  • Analysis of the effects of specific dopamine agonists and antagonists on physiological systems.
  • Examination of therapeutic uses in neurological, endocrine, and psychiatric disorders.

Related Experiment Videos

Main Results:

  • Dopamine-2 (DA2) agonists (e.g., bromocriptine, pergolide) decrease norepinephrine release, lower blood pressure, and can reduce heart rate. They are used for Parkinson's disease and hyperprolactinemia.
  • Dopamine-1 (DA1) agonists (e.g., fenoldopam) lower peripheral resistance and blood pressure but increase heart rate and renin-aldosterone activity.
  • DA2 antagonists (e.g., metoclopramide, haloperidol) are used for gastrointestinal disorders and psychosis, while DA1 antagonists (e.g., clozapine) treat schizophrenia.

Conclusions:

  • Dopamine receptor agonists and antagonists represent critical therapeutic agents across multiple medical disciplines.
  • Targeting specific dopamine receptor subtypes offers diverse physiological effects and treatment options for various diseases.